ACIST CVi® Economic Value Model
The complete economic value model is a set of robust variables and calculations based on extensive research from peer-reviewed published sources. This abbreviated website version is meant to give you an idea of the value ACIST CVi® may provide.
By entering the annual number of coronary catheterization procedures above, we can provide a rough estimate of the savings you/your hospital may realize by using CVi.
US procedure data showed the average break down between diagnostic versus PCI procedures was 65% to 35%1. Meta-analysis showed average contrast use per cardiac catherization procedure with hand manifold was around 202 mL, and ACIST CVi reduced the contrast use by 22% per procedure2. Additionally, the meta-analysis showed ACIST CVi® reduced overall incidence of CI-AKI by 15%2. The average annual incidence of CI-AKI is around 8.1% post PCI procedures and 11.9% post diagnostic procedures3. Average cost of contrast media is assumed to be $0.12 per mL. CI-AKI cost is around $10,459 in the model 4,5.
- US Procedure data by physicians. Data on file. Decision Resources Group (DRG) 2018
- Meta-analysis of the effect of automated contrast injection devices versus manual injection and contrast volume on risk of contrast-induced nephropathy. Minsinger KD et al. Am J Cardiol. 2014;113(1) :49-53
- Incidence and in-hospital Mortality of Acute Kidney Injury (AKI) and Dialysis-Requiring AKI (AKI-D) after Cardiac Catherization in the National Inpatient Sample. Brown et al. J Am Heart Assoc. 2016;5:e002739.
- Incremental Cost of Acute Kidney Injury after Percutaneous Coronary Intervention in the United States Amin et al. Am J Cardiol 2020;125:29−33. 2020;125(29-33).
- CPI for All Urban Consumers (CPI-U). Medical care in U.S. city average, all urban consumers, seasonally adjusted Years 2010-2020. Bureau of Labor Statistics.
Get Your Complete Calculations
You estimated total cost savings with ACIST CVi® could be $ per year based on reduction in contrast and CI-AKI incidence with CVi. The total length of hospital days could be reduced by days.
Want to learn more? Please provide your information below, and your ACIST representative will reach out to you to walk through the full model and discuss how ACIST's solutions may help you/your hospital save.
Disclaimer: The economic model is provided for projecting possible outcomes under certain clinical and economic scenarios. The results may vary if other factors are accounted for, and therefore these results are estimates of cost savings. The information is intended to be a general reference of any cost savings. ACIST makes no guarantee that the use of products will result in exact cost savings provided here. ACIST does not intend to nor does ACIST promote the use of any products outside of their approved labeling.